Shancheng Ren

8.4k total citations · 2 hit papers
78 papers, 3.5k citations indexed

About

Shancheng Ren is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Shancheng Ren has authored 78 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 34 papers in Molecular Biology and 30 papers in Cancer Research. Recurrent topics in Shancheng Ren's work include Prostate Cancer Treatment and Research (32 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Cancer-related molecular mechanisms research (14 papers). Shancheng Ren is often cited by papers focused on Prostate Cancer Treatment and Research (32 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Cancer-related molecular mechanisms research (14 papers). Shancheng Ren collaborates with scholars based in China, United States and Canada. Shancheng Ren's co-authors include Yinghao Sun, Fubo Wang, Chuanliang Xu, Xu Gao, Yasheng Zhu, Ji Lu, Min Wei, Yinghao Sun, Yu‐Tian Xiao and Wenyi Wei and has published in prestigious journals such as Nature, Nature Genetics and PLoS ONE.

In The Last Decade

Shancheng Ren

72 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance

2017 736 citations Jinfang Zhang, Xia Bu et al. Nature profile →
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials

2022 149 citations Weidong Xu, Shancheng Ren et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shancheng Ren China	30	2.1k	1.4k	992	895	391	78	3.5k
Humam Kadara United States	34	1.8k 0.8×	900 0.6×	914 0.9×	1.1k 1.3×	468 1.2×	95	3.2k
Nayiyuan Wu China	24	1.7k 0.8×	1.1k 0.8×	557 0.6×	742 0.8×	426 1.1×	84	2.9k
Xin Dong China	29	1.9k 0.9×	986 0.7×	799 0.8×	849 0.9×	548 1.4×	75	3.0k
Jun Lü China	28	1.4k 0.7×	946 0.7×	608 0.6×	863 1.0×	222 0.6×	181	2.7k
Xinhua Xie China	33	2.1k 1.0×	1.8k 1.2×	524 0.5×	870 1.0×	229 0.6×	76	3.1k
Dong Lin Canada	30	1.7k 0.8×	1.0k 0.7×	1.1k 1.1×	593 0.7×	210 0.5×	99	2.9k
Germana Castelli Italy	29	1.6k 0.8×	950 0.7×	478 0.5×	798 0.9×	400 1.0×	97	3.1k
Luca Quagliata Switzerland	29	1.7k 0.8×	1.4k 1.0×	450 0.5×	640 0.7×	446 1.1×	73	2.9k
Seema Sethi United States	33	1.9k 0.9×	1.2k 0.9×	614 0.6×	957 1.1×	160 0.4×	90	3.1k
Yin Sun China	35	3.1k 1.5×	1.6k 1.1×	724 0.7×	758 0.8×	296 0.8×	116	4.2k

Countries citing papers authored by Shancheng Ren

Since Specialization

Citations

This map shows the geographic impact of Shancheng Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shancheng Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shancheng Ren more than expected).

Fields of papers citing papers by Shancheng Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shancheng Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shancheng Ren. The network helps show where Shancheng Ren may publish in the future.

Co-authorship network of co-authors of Shancheng Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Shancheng Ren. A scholar is included among the top collaborators of Shancheng Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shancheng Ren. Shancheng Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Dingtao, Yuan Chen, Qingyang Chen, et al.. (2025). The impact of dietary fat and fatty acid consumption on human health: A comprehensive review of meta-analyses and the Global Burden of Disease study 2021. Trends in Food Science & Technology. 160. 105002–105002. 2 indexed citations

Chang, Yifan, et al.. (2025). Extraperitoneal single‐site robot‐assisted radical prostatectomy with extended pelvic lymph node dissection: technique and experience. British Journal of Urology. 135(4). 700–705. 1 indexed citations

Fan, Zhiguo, Xianzhi Zhao, Weidong Xu, et al.. (2025). NEoAdjuvant radiohormonal therapy versus standard of care for oligometastatic prostate cancer (NEAR-TOP): study protocol of a multicenter, open-label, randomised controlled trial. BMC Cancer. 25(1). 768–768.

Luo, Leo Y., et al.. (2024). P3.12E.03 Anti-Tumor Efficacy of HRS-4642 and its Potential Combination with Proteasome Inhibition in KRAS G12D-Mutant Cancer. Journal of Thoracic Oncology. 19(10). S351–S352.

Chang, Yifan, et al.. (2023). Pelvic drain placement after robot-assisted radical prostatectomy: meta-analysis. BJS Open. 7(6). 2 indexed citations

Zhao, Kai, Dong Zhang, Shangqian Wang, et al.. (2023). Exploring the potential mechanisms of impairment on genitourinary system associated with coronavirus disease 2019 infection: Bioinformatics and molecular simulation analyses. Asian journal of urology. 10(3). 344–355. 1 indexed citations

Liu, Fei, Zixian Wang, Xiaofan Li, et al.. (2022). Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors. Cancer Communications. 43(2). 214–224. 9 indexed citations

Liu, Fei, Xiaolei Shi, Fang‐Ming Wang, et al.. (2022). Evaluation and multi-institutional validation of a novel urine biomarker lncRNA546 to improve the diagnostic specificity of prostate cancer in PSA gray-zone. Frontiers in Oncology. 12. 946060–946060. 3 indexed citations

Xu, Huan, Junyi Chen, Zhi Cao, et al.. (2022). Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy. Cancer Biology and Medicine. 19(9). 1–19. 5 indexed citations

10.

Zhou, Tie, Weidong Xu, Wei Zhang, et al.. (2020). Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer. European Journal of Cancer. 134. 29–40. 21 indexed citations

11.

Ren, Xiaohan, Shangqian Wang, Xinglin Chen, et al.. (2020). <p>Multiple Expression Assessments of ACE2 and TMPRSS2 SARS-CoV-2 Entry Molecules in the Urinary Tract and Their Associations with Clinical Manifestations of COVID-19</p>. Infection and Drug Resistance. Volume 13. 3977–3990. 38 indexed citations

12.

Gordon, Jacob A., Ankur Midha, Fatemeh Derakhshan, et al.. (2019). Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate Cancer. Cancer Research. 79(13). 3320–3331. 46 indexed citations

13.

Zhu, Shimiao, Hao Tian, Xiaodan Niu, et al.. (2019). Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer. Oncogene. 38(24). 4875–4884. 32 indexed citations

14.

Yang, Yue, Tao Sun, Lin Zhao, et al.. (2019). Efficacy and Safety of Combined Androgen Blockade with Antiandrogen for Advanced Prostate Cancer. Current Oncology. 26(1). 4203–4203. 8 indexed citations

15.

Zhang, Jinfang, Xia Bu, Haizhen Wang, et al.. (2017). Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance. Nature. 553(7686). 91–95. 736 indexed citations breakdown →

16.

Ding, Qiang, Guopeng Yu, Rong Na, et al.. (2015). Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography. Asian Journal of Andrology. 18(4). 633–633. 11 indexed citations

17.

Li, Yanyan, Fengxia Du, Xiao Han, et al.. (2014). Histone H4 Lys 20 methyltransferase SET8 promotes androgen receptor-mediated transcription activation in prostate cancer. Biochemical and Biophysical Research Communications. 450(1). 692–696. 28 indexed citations

18.

Xu, Chuanliang, Weidong Xu, Shancheng Ren, et al.. (2013). Establishment of a Chinese bladder cancer cell line (T921) with high metastatic activity. In Vitro Cellular & Developmental Biology - Animal. 49(9). 668–678. 2 indexed citations

19.

Ren, Shancheng, Fubo Wang, Jian Shen, et al.. (2013). Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. European Journal of Cancer. 49(13). 2949–2959. 271 indexed citations

20.

Cui, Zilian, Shancheng Ren, Ji Lu, et al.. (2012). The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Urologic Oncology Seminars and Original Investigations. 31(7). 1117–1123. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact